Literature DB >> 6086627

Cyclic AMP regulation of pro-vasoactive intestinal polypeptide/PHM-27 synthesis in human neuroblastoma cells.

Y Hayakawa, K Obata, N Itoh, N Yanaihara, H Okamoto.   

Abstract

The mechanism of N6,O2'-dibutyryl adenosine 3':5'-monophosphate (Bt2cAMP) induction of pro-vasoactive intestinal polypeptide (VIP)/PHM-27 biosynthesis was investigated in human neuroblastoma cells in culture. When neuroblastoma cells were grown for 48 h in the presence of 1 mM Bt2cAMP, the synthesis of pro-VIP/PHM-27 was stimulated 11-fold. The amount of prepro-VIP/PHM-27 mRNA determined both by hybridization with cloned prepro-VIP/PHM-27 cDNA and a reticulocyte cell-free translation assay was also increased 11-fold in the Bt2cAMP-induced cells. Transcription of prepro-VIP/PHM-27 mRNA in isolated nuclei was observed in induced cells, but not in uninduced cells. Blot hybridization with prepro-VIP/PHM-27 cDNA of total nuclear RNA isolated from neuroblastoma cells revealed an RNA species corresponding to mature prepro-VIP/PHM-27 mRNA, and the amount of the RNA was markedly increased in the induced cells. The quantity of VIP/PHM-27 gene in the DNA of neuroblastoma cells was analyzed after hydrolysis with a restriction endonuclease, EcoRI. However, VIP/PHM-27 gene was not amplified in the induced cells. These results indicate that Bt2cAMP-induced pro-VIP/PHM-27 synthesis is achieved by enhancing the transcription rate of prepro-VIP/PHM-27 mRNA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086627

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer.

Authors:  J S Fink; M Verhave; S Kasper; T Tsukada; G Mandel; R H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 2.  Activity-dependent regulation of gene expression in muscle and neuronal cells.

Authors:  R Laufer; J P Changeux
Journal:  Mol Neurobiol       Date:  1989 Spring-Summer       Impact factor: 5.590

Review 3.  Regulation of VIP gene expression in general. Human lung cancer cells in particular.

Authors:  A Davidson; T W Moody; I Gozes
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.

Authors:  S Linder; T Barkhem; A Norberg; H Persson; M Schalling; T Hökfelt; G Magnusson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome.

Authors:  M Bodner; M Fridkin; I Gozes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury.

Authors:  R P Mohney; R E Zigmond
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 7.  VIP: molecular biology and neurobiological function.

Authors:  I Gozes; D E Brenneman
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

8.  Estrogen regulation of vasoactive intestinal peptide mRNA in rat hypothalamus.

Authors:  I Gozes; H Werner; M Fawzi; A Abdelatty; Y Shani; M Fridkin; Y Koch
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

9.  Phenotypic plasticity in adult sympathetic neurons: changes in neuropeptide expression in organ culture.

Authors:  R E Zigmond; H Hyatt-Sachs; C Baldwin; X M Qu; Y Sun; T W McKeon; R C Schreiber; U Vaidyanathan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.